The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes

Respiratory Research

Volumn 15, Issue 1, 2014, Pages

  Carolan, Brendan J ^a,b   Hughes, Grant ^c   Morrow, Jarrett ^d   Hersh, Craig P ^d   O'Neal, Wanda K ^e   Rennard, Stephen ^f   Pillai, Sreekumar G ^g,l   Belloni, Paula ^h,l   Cockayne, Debra A ⁱ   Comellas, Alejandro P ^j   Han, Meilan ^k   Zemans, Rachel L ^a,b   Kechris, Katerina ^c   Bowler, Russell P ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^g Preclinical Development Pathology   (United States)

^h GENENTECH INC   (United States)

ⁱ UNIVERSITY OF IOWA   (United States)

^j UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^k ELI LILLY AND COMPANY   (United States)

^l Boston Scientific   (United States)

more..

Author keywords

Biomarkers; CCL20; COPD; Emphysema; ICAM1; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CADHERIN; CADHERIN 1; CADHERIN 13; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12P40; INTERLEUKIN 2 RECEPTOR ALPHA; LATENCY ASSOCIATED PEPTIDE; LOW DENSITY LIPOPROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE CELL ADHESION MOLECULE; RANTES; SUPEROXIDE DISMUTASE; THYROXINE BINDING GLOBULIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RADIOLOGICAL PARAMETERS; SEX DIFFERENCE; SMOKING HABIT; VERY ELDERLY; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; LUNG EMPHYSEMA; MIDDLE AGED; MULTICENTER STUDY; PHENOTYPE; RADIOGRAPHY; STANDARDS; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; BIOMARKERS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84964315666     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-014-0127-9     Document Type: Article

References (49)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013, 187 (4): 347-365. 10.1164/rccm.201204-0596PP.
2. Fletcher CM, Gilson JG, Hugh-Jones P, Scadding JG: Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions. Thorax. 1959, 14: 286-299. 10.1136/thx.14.4.286.
3. Mohamed Hoesein FA, Zanen P, Boezen HM, Groen HJ, van Ginneken B, de Jong PA, Postma DS, Lammers JW: Lung function decline in male heavy smokers relates to baseline airflow obstruction severity. Chest. 2012, 142 (6): 1530-1538. 10.1378/chest.11-2837.
4. Li Y, Swensen SJ, Karabekmez LG, Marks RS, Stoddard SM, Jiang R, Worra JB, Zhang F, Midthun DE, de Andrade M, Song Y, Yang P: Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment. Cancer Prev Res (Phila). 2011, 4 (1): 43-50. 10.1158/1940-6207.CAPR-10-0151.
5. de Torres JP, Bastarrika G, Wisnivesky JP, Alcaide AB, Campo A, Seijo LM, Pueyo JC, Villanueva A, Lozano MD, Montes U, Montuenga L, Zulueta JJ: Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 2007, 132 (6): 1932-1938. 10.1378/chest.07-1490.
6. Haruna A, Muro S, Nakano Y, Ohara T, Hoshino Y, Ogawa E, Hirai T, Niimi A, Nishimura K, Chin K, Mishima M: CT scan findings of emphysema predict mortality in COPD. Chest. 2010, 138 (3): 635-640. 10.1378/chest.09-2836.
7. Bastarrika G, Wisnivesky JP, Pueyo JC, Diaz L, Arraiza M, Villanueva A, Alcaide AB, Campo A, Seijo L, de Torres JP, Zulueta JJ: Low-dose volumetric computed tomography for quantification of emphysema in asymptomatic smokers participating in an early lung cancer detection trial. J Thorac Imaging. 2009, 24 (3): 206-211. 10.1097/RTI.0b013e3181a65263.
8. Kirby M, Coxson HO: Computed tomography biomarkers of pulmonary emphysema. COPD. 2013, 10 (4): 547-550. 10.3109/15412555.2013.811992.
9. Schroeder JD, McKenzie AS, Zach JA, Wilson CG, Curran-Everett D, Stinson DS, Newell JD, Lynch DA: Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. AJR Am J Roentgenol. 2013, 201 (3): W460-W470. 10.2214/AJR.12.10102.
10. Mendoza CS, Washko GR, Ross JC, Diaz AA, Lynch DA, Crapo JD, Silverman EK, Acha B, Serrano C, Estepar RS: Emphysema Quantification in a Multi-Scanner Hrct Cohort Using Local Intensity Distributions.Proc IEEE Int Symp Biomed Imaging 2013: 474-477.
11. Parr DG, Dirksen A, Piitulainen E, Deng C, Wencker M, Stockley RA: Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency. Respir Res. 2009, 10: 75-10.1186/1465-9921-10-75.
12. Stoller JK, Aboussouan LS: A review of alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012, 185 (3): 246-259. 10.1164/rccm.201108-1428CI.
13. Cheng DT, Kim DK, Cockayne DA, Belousov A, Bitter H, Cho MH, Duvoix A, Edwards LD, Lomas DA, Miller BE, Reynaert N, Tal-Singer R, Wouters EF, Agusti A, Fabbri LM, Rames A, Visvanathan S, Rennard SI, Jones P, Parmar H, MacNee W, Wolff G, Silverman EK, Mayer RJ, Pillai SG: Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013, 188 (8): 948-957. 10.1164/rccm.201302-0247OC.
14. Carolan BJ, Kim YI, Williams AA, Kechris K, Lutz S, Reisdorph N, Bowler RP: The association of adiponectin with computed tomography phenotypes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013, 188 (5): 561-566. 10.1164/rccm.201212-2299OC.
15. Miller M, Ramsdell J, Friedman PJ, Cho JY, Renvall M, Broide DH: Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema. J Allergy Clin Immunol. 2007, 120 (5): 1118-1125. 10.1016/j.jaci.2007.08.045.
16. Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG: Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 186 (10): 982-988. 10.1164/rccm.201206-1113OC.
17. Gaki E, Kontogianni K, Papaioannou AI, Bakakos P, Gourgoulianis KI, Kostikas K, Alchanatis M, Papiris S, Loukides S: Associations between BODE index and systemic inflammatory biomarkers in COPD. COPD. 2011, 8 (6): 408-413. 10.3109/15412555.2011.619599.
18. Rosenberg SR, Kalhan R: Biomarkers in chronic obstructive pulmonary disease. Transl Res. 2012, 159 (4): 228-237. 10.1016/j.trsl.2012.01.019.
19. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD: Genetic epidemiology of copd (copedgene) study design. COPD. 2010, 7: 32-43. 10.3109/15412550903499522.
20. Jones PW: Tesra (treatment of emphysema with selective retinoid agonist) study results. Am J Respir Crit Care Med. 2011, 183: A6418-
21. Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, Curtis JL, Criner GJ, Kim V, Bowler RP, Hanania NA, Anzueto AR, Make BJ, Hokanson JE, Crapo JD, Silverman EK, Martinez FJ, Washko GR: Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011, 261 (1): 274-282. 10.1148/radiol.11110173.
22. O'Neal WK, Anderson W, Basta PV, Carretta EE, Doerschuk CM, Barr RG, Bleecker ER, Christenson SA, Curtis JL, Han MK, Hansel NN, Kanner RE, Kleerup EC, Martinez FJ, Miller BE, Peters SP, Rennard SI, Scholand MB, Tal-Singer R, Woodruff PG, Couper DJ, Davis SM: Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study. J Transl Med. 2014, 12: 9-10.1186/1479-5876-12-9.
23. Stouffer SA, Suchman EA, DeVinney LC, Star SA, Williams RM: The American Soldier, Vol. 1: Adjustment during Army Life. 1949, Princeton University Press, Princeton
24. Murdoch DR, O'Brien KL, Scott JA, Karron RA, Bhat N, Driscoll AJ, Knoll MD, Levine OS: Breathing new life into pneumonia diagnostics. J Clin Microbiol. 2009, 47 (11): 3405-3408. 10.1128/JCM.01685-09.
25. Buckley ST, Ehrhardt C: The receptor for advanced glycation end products (RAGE) and the lung. J Biomed Biotechnol. 2010, 2010: 917108-10.1155/2010/917108.
26. Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A: Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther. 2005, 7 (4): R817-R824. 10.1186/ar1749.
27. Falcone C, Bozzini S, Guasti L, D'Angelo A, Capettini AC, Paganini EM, Falcone R, Moia R, Gazzaruso C, Pelissero G: Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease. Scientific World Journal. 2013, 2013: 584504-10.1155/2013/584504.
28. Alexiou P, Chatzopoulou M, Pegklidou K, Demopoulos VJ: RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem. 2010, 17 (21): 2232-2252. 10.2174/092986710791331086.
29. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA: Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med. 2006, 173 (9): 1008-1015. 10.1164/rccm.200509-1477OC.
30. Smith DJ, Yerkovich ST, Towers MA, Carroll ML, Thomas R, Upham JW: Reduced soluble receptor for advanced glycation end-products in COPD. Eur Respir J. 2011, 37 (3): 516-522. 10.1183/09031936.00029310.
31. Cockayne DA, Cheng DT, Waschki B, Sridhar S, Ravindran P, Hilton H, Kourteva G, Bitter H, Pillai SG, Visvanathan S, Muller KC, Holz O, Magnussen H, Watz H, Fine JS: Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity. PLoS One. 2012, 7 (6): e38629-10.1371/journal.pone.0038629.
32. Miniati M, Monti S, Basta G, Cocci F, Fornai E, Bottai M: Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respir Res. 2011, 12: 37-10.1186/1465-9921-12-37.
33. Wu L, Ma L, Nicholson LF, Black PN: Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. Respir Med. 2011, 105 (3): 329-336. 10.1016/j.rmed.2010.11.001.
34. Stogsdill MP, Stogsdill JA, Bodine BG, Fredrickson AC, Sefcik TL, Wood TT, Kasteler SD, Reynolds PR: Conditional overexpression of receptors for advanced glycation end-products in the adult murine lung causes airspace enlargement and induces inflammation. Am J Respir Cell Mol Biol. 2013, 49 (1): 128-134. 10.1165/rcmb.2013-0013OC.
35. Di Stefano A, Maestrelli P, Roggeri A, Turato G, Calabro S, Potena A, Mapp CE, Ciaccia A, Covacev L, Fabbri LM, Saetta M: Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med. 1994, 149 (3 Pt 1): 803-810. 10.1164/ajrccm.149.3.7509705.
36. El-Deek SE, Makhlouf HA, Saleem TH, Mandour MA, Mohamed NA: Surfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary disease. Med Princ Pract. 2013, 22 (5): 469-474. 10.1159/000349934.
37. Huang H, Jiang H, Kong X, Liu T, Tan Z, Chen P, Luo H: Association of intercellular adhesion molecule-1 gene K469E polymorphism with chronic obstructive pulmonary disease. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012, 37 (1): 78-83.
38. Lopez-Campos JL, Calero C, Arellano-Orden E, Marquez-Martin E, Cejudo-Ramos P, Ortega Ruiz F, Montes-Worboys A: Increased levels of soluble ICAM-1 in chronic obstructive pulmonary disease and resistant smokers are related to active smoking. Biomark Med. 2012, 6 (6): 805-811. 10.2217/bmm.12.64.
39. Aaron CP, Schwartz JE, Tracy R, Hoffman EA, Austin JHM, Oelsner EC, Donohue KM, Kalhan R, Jacobs D, Barr RG: Intercellular Adhesion Molecule (icam)1 And Longitudinal Change In Percent Emphysema And Lung Function: The MESA Lung Study. Am J Respir Crit Care Med. 2013, 187: A1523-
40. Dieu-Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, Vicari A, Lebecque S, Dezutter-Dambuyant C, Schmitt D, Zlotnik A, Caux C: Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med. 2000, 192 (5): 705-718. 10.1084/jem.192.5.705.
41. Meuronen A, Majuri ML, Alenius H, Mantyla T, Wolff H, Piirila P, Laitinen A: Decreased cytokine and chemokine mRNA expression in bronchoalveolar lavage in asymptomatic smoking subjects. Respiration. 2008, 75 (4): 450-458. 10.1159/000114855.
42. Bracke KR, D'Hulst AI, Maes T, Moerloose KB, Demedts IK, Lebecque S, Joos GF, Brusselle GG: Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol. 2006, 177 (7): 4350-4359. 10.4049/jimmunol.177.7.4350.
43. Gall TM, Frampton AE: Gene of the month: E-cadherin (CDH1). J Clin Pathol. 2013, 66 (11): 928-932. 10.1136/jclinpath-2013-201768.
44. Milara J, Peiro T, Serrano A, Cortijo J: Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax. 2013, 68 (5): 410-420. 10.1136/thoraxjnl-2012-201761.
45. Tsuduki KNH, Nakajima T, Tsujimura S, Yoshida S, Takahashi E, Nakamura M, Minematsu N, Tateno H, Ishizaka A: Genetic polymorphism of e-cadherin and COPD. Am J Respir Crit Care Med. 2009, 179: A2999-
46. Kasahara DI, Williams AS, Benedito LA, Ranschr B, Kobzik L, Hug C, Shore SA: Role of the adiponectin binding protein, t-cadherin (cdh13), in pulmonaryt responses to subacute ozone. PLoS One. 2013, 8: e65829-10.1371/journal.pone.0065829.
47. Takeuchi T, Misaki A, Fujita J, Sonobe H, Ohtsuki Y: T-cadherin (cdh13, h-cadherin) expression downtregulated surfactant protein d in bronchioloalveolar cells. Virchows Arch. 2001, 438: 370-375. 10.1007/s004280000385.
48. Faner R, Tal-Singer R, Riley JH, Celli B, Vestbo J, MacNee W, Bakke P, Calverley PM, Coxson H, Crim C, Edwards LD, Locantore N, Lomas DA, Miller BE, Rennard SI, Wouters EF, Yates JC, Silverman EK, Agusti A: Lessons from ECLIPSE: a review of COPD biomarkers. Thorax. 2013, 69 (7): 666-672. 10.1136/thoraxjnl-2013-204778.
49. Agusti A, Sin DD: Biomarkers in COPD. Clin Chest Med. 2014, 35 (1): 131-141. 10.1016/j.ccm.2013.09.006.